The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Recommendations for pharmacological rate control during atrial fibrillation [1]

Recommendations for pharmacological rate control during atrial fibrillation ^[1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Recommendations for pharmacological rate control during atrial fibrillation [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for preventing thromboembolism [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for pharmacological cardioversion of atrial fibrillation [1]

Class I

Class IIa

Class IIb

Class III

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter [1]

Class I

Class IIa

Class III

Recommendation for pharmacological enhancement of direct-current cardioversion [1]

Class IIa

Class IIb

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion [1]

Class I

Class IIa

Recommendations for maintenance of sinus rhythm [1]

Class I

Class IIa

Class III

Recommendations for patients with postoperative atrial fibrillation [1]

Class I

Class IIa

Class IIb

Recommendations for patients with acute myocardial infarction [1]

Class I

Class IIa

Class III

Recommendations for patients with Wolff Parkinson White syndrome (WPW) [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for patients with hyperthyroidism [1]

Class I

Recommendations for pregnant patients [1]

Class I

Class IIb

Recommendations for patients with Hypertrophic Cardiomyopathy [1]

Class I

Class IIa

Recommendations for patients with Pulmonary Hypertension [1]

Class I

Class III

References

Looking for the patient version?

Recommendations for pharmacological rate control during atrial fibrillation ^[1]

Recommendations for preventing thromboembolism ^[1]

Recommendations for pharmacological cardioversion of atrial fibrillation ^[1]

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter ^[1]

Recommendation for pharmacological enhancement of direct-current cardioversion ^[1]

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion ^[1]

Recommendations for maintenance of sinus rhythm ^[1]

Recommendations for patients with postoperative atrial fibrillation ^[1]

Recommendations for patients with acute myocardial infarction ^[1]

Recommendations for patients with Wolff Parkinson White syndrome (WPW) ^[1]

Recommendations for patients with hyperthyroidism ^[1]

Recommendations for pregnant patients ^[1]

Recommendations for patients with Hypertrophic Cardiomyopathy ^[1]

Recommendations for patients with Pulmonary Hypertension ^[1]